1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Characteristics of patients and dural AVFs
Group 1 Group 2 Occluded AVF (n = 7) Partial AVF (n = 6) P Value Deteriorating AVF (n = 6) Stationary AVF (n = 7) Improving AVF (n = 3) P Value Age 49.7 ± 13.5 49.3 ± 15.4 .96 47.8 ± 14.6 45.0 ± 8.7 54.7 ± 2.1 .46 Sex .56 .36 Men 1 (14) 2 (33) 0 (0) 2 (29) 1 (33) Women 6 (86) 4 (67) 6 (100) 5 (71) 2 (67) Location of dural AVF .78 Cavernous sinus 2 (29) 1 (17) 1 1 (17) 1 (14) 1 (33) Noncavernous sinus 5 (71) 5 (83) 5 (83) 6 (86) 2 (67) Type of dural AVF .55 I, IIa 6 (86) 3 (50) .27 4 (67) 6 (86) 3 (100) IIb, IIa+b, III–V 1 (14) 3 (50) 2 (33) 1 (14) 0 (0)
Note.—Data are the number (percentage) or mean ± SD.